BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10664158)

  • 1. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
    Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cortical and medullary thymic epithelial antigens in thymomas. An immunohistological study of 14 cases including a characterization of the lymphocytic compartment.
    Hofmann WJ; Pallesen G; Möller P; Kunze WP; Kayser K; Otto HF
    Histopathology; 1989 May; 14(5):447-63. PubMed ID: 2786836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
    Chan JK; Tsang WY; Seneviratne S; Pau MY
    Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
    Quintanilla-Martinez L; Wilkins EW; Ferry JA; Harris NL
    Hum Pathol; 1993 Sep; 24(9):958-69. PubMed ID: 8253462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
    Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
    Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H
    Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Muller-Hermelink system.
    Kuo TT; Lo SK
    Hum Pathol; 1993 Jul; 24(7):766-71. PubMed ID: 8319955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological analysis of thymic tumors with PE-35 monoclonal antibody reactive with medullary thymic epithelium.
    Takahashi T; Ueda R; Nishida K; Namikawa R; Fukami H; Matsuyama M; Masaoka A; Imaizumi M; Takahashi T
    Cancer Res; 1988 Apr; 48(7):1896-903. PubMed ID: 2450640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
    van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO
    Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoma: an immunohistochemical study.
    Chan WC; Zaatari GS; Tabei S; Bibb M; Brynes RK
    Am J Clin Pathol; 1984 Aug; 82(2):160-6. PubMed ID: 6380266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
    Papla B; Rudnicka L; Dubiel-Bigaj M; Malinowski E
    Pol J Pathol; 1998; 49(4):251-65. PubMed ID: 10323079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
    Nomori H; Ishihara T; Torikata C
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):93-100. PubMed ID: 1691772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms.
    Pomplun S; Wotherspoon AC; Shah G; Goldstraw P; Ladas G; Nicholson AG
    Histopathology; 2002 Feb; 40(2):152-8. PubMed ID: 11952859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes.
    Kondo K; Mukai K; Sato Y; Matsuno Y; Shimosato Y; Monden Y
    Am J Surg Pathol; 1990 Dec; 14(12):1139-47. PubMed ID: 2252104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoma--a study of 60 cases in Singapore.
    Tan PH; Sng IT
    Histopathology; 1995 Jun; 26(6):509-18. PubMed ID: 7665142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistologic study of the epithelial components of 81 cases of thymoma.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O; Hirokawa K; Ueda R
    Cancer; 1992 May; 69(10):2463-8. PubMed ID: 1373667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between structure and T-lymphocyte maturation in human thymomas. Enzyme histochemical and immunohistological studies.
    Palestro G; Valente G; Novero D; Stramignoni D; Geuna M; Rosai J
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 52(5):389-402. PubMed ID: 2883762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymomas and thymic carcinomas. A retrospective investigation with histological reclassification.
    Engel P; Pilsgaard B; Francis D
    APMIS; 1995 Sep; 103(9):671-8. PubMed ID: 7488389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.